CRP and cancer: More recently, a novel combination model of CRP and albumin—CRP/Alb ratio—has also been increasingly appreciated since it could serve as a predictor of a clinical outcome in patients with serious infectious disease and those with cancers [31, 32, 34, 35, 44].